Questionnaire

1. The basal-bolus regimen involves using a long-acting insulin injected once or twice a day and a short-acting insulin injected prior to meals.

2. When PWD are switched from twice-daily NPH insulin to glargine u100 administered once daily, to reduce the risk of hypoglycaemia, the initial dose of glargine u100 should be reduced by approximately 20 % and then the regimen should be adjusted individually.

3. What level of glucose is recognised as representing a clinically significant hypoglycaemic event?

4. 24-year-old woman with Type 1 DM and visual impairment is on a basal bolus insulin regimen with 10 Units of regular human insulin before each meal, and 30 Units of NPH insulin at bedtime. What doses of analogue insulins would you recommend when switching her?

5. Once-daily NPH insulin can be switched to inulin glargine unit for unit, without any dose adjustment.